ISPOR SPONSORING SESSION AT DIA 2016 THIS JUNE

Published Apr 5, 2016
ANNOUNCEMENT

SOCIETY’S PRESIDENT-ELECT, LOU GARRISON, LEADING WORKSHOP

Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is attending and contributing to the Drug Information Association (DIA) Annual Meeting being held June 26-30, 2016 in Philadelphia, PA, USA.  ISPOR will be sponsoring a preconference workshop on Sunday, June 26 at DIA 2016. ISPOR President-Elect Lou Garrison, PhD will be one of the instructors for the half-day session entitled, The Evolving Role of Payers in Drug Development: Pricing, Pharmacoeconomics, and Health Technology Assessment. ISPOR is offering this preconference tutorial at this event to provide expanded access to educational resources as part of its mission to promote health economics and outcomes research (HEOR) excellence to improve decision making for health globally. For additional information, please contact Betsy Lane, director, chief marketing and communications officer at BLane@ispor.org or 609-586-4981 x112.

###

Related Stories

ISPOR Europe 2026 Plenaries Announced

Sep 30, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Europe 2026 conference. The conference is the leading global event in Europe for health economics and outcomes research (HEOR) and is scheduled for 8-11 November in Vienna, Austria with the theme, “Shaping the Future of Access Through Science and Policy.”

ISPOR and ISPE Publish Joint Real-World Evidence Transparency Position Statement

Sep 29, 2026

Transparency in research enables the public and decision makers to trust the science that underpins real-world evidence (RWE). ISPOR—The Professional Society for Health Economics and Outcomes Research and the International Society for Pharmacoepidemiology (ISPE) have published a joint RWE Transparency Position Statement.

New Study Sheds Light on QALY and Disability Debate

Sep 28, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a study showing no evidence that the use of quality-adjusted life years (QALYs) inherently disadvantages people with disabilities.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×